Zenas BioPharma, Inc. Increase Decrease In Operating Lease Liability
Zenas BioPharma, Inc. (ZBIO) reported Increase Decrease In Operating Lease Liability of -$481.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- Zenas BioPharma, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$270.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$211.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$245.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$211.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for fiscal 2025 was -$902.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for fiscal 2024 was -$673.00K.
- Zenas BioPharma, Inc. increase decrease in operating lease liability for fiscal 2023 was -$714.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$481.00K 10-Q · filed 2026-08-13 | -$726.00K derived: sum of 3 quarters · filed 2026-08-13 | -$937.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$211.00K 10-Q · filed 2026-05-13 | -$456.00K derived: sum of 2 quarters · filed 2026-05-13 | -$667.00K derived: sum of 3 quarters · filed 2026-05-13 | -$891.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$456.00K derived: sum of 2 quarters · filed 2026-03-16 | -$680.00K derived: sum of 3 quarters · filed 2026-08-13 | -$902.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$211.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$435.00K derived: sum of 2 quarters · filed 2026-08-13 | -$657.00K 10-Q · filed 2025-11-12 | -$901.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$446.00K 10-Q · filed 2026-08-13 | -$690.00K derived: sum of 3 quarters · filed 2026-08-13 | -$814.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$222.00K 10-Q · filed 2026-05-13 | -$466.00K derived: sum of 2 quarters · filed 2026-05-13 | -$590.00K derived: sum of 3 quarters · filed 2026-05-13 | -$731.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$368.00K derived: sum of 2 quarters · filed 2026-03-16 | -$509.00K derived: sum of 3 quarters · filed 2026-03-16 | -$673.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$265.00K derived: sum of 2 quarters · filed 2025-11-12 | -$429.00K 10-Q · filed 2025-11-12 | -$580.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$305.00K 10-Q · filed 2025-08-12 | -$456.00K derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$164.00K 10-Q · filed 2025-05-15 | -$315.00K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$714.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | -$563.00K 10-Q · filed 2024-11-12 |